Aditxt Appoints Sylvia Hermina to Board of DirectorsAditxt, Inc. (NASDAQ: ADTX) has recently announced the appointment of Ms. Sylvia Hermina to its Board of Directors. The decision was made on October 23, 2024, by the Board of Directors in

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Aditxt’s 8K filing here.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.